Roxoperone is a chemical compound classified as an antipsychotic and anxiolytic agent, primarily used in the treatment of anxiety and related disorders. It belongs to the class of compounds known as butyrophenones, which are characterized by their ability to modulate neurotransmitter activity in the brain, particularly dopamine. Roxoperone exhibits a unique pharmacological profile, providing sedative and anxiolytic effects while minimizing extrapyramidal side effects commonly associated with other antipsychotics. The compound is typically administered in oral form and is known for its relatively rapid onset of action. Its chemical structure includes a butyrophenone moiety, which contributes to its therapeutic effects. Roxoperone has been studied for its efficacy in various clinical settings, although its use may be limited in some regions due to regulatory considerations. As with any medication, potential side effects and contraindications should be carefully evaluated by healthcare professionals before prescribing. Overall, roxoperone represents a significant option in the pharmacological management of anxiety disorders.

roxoperone

2804-00-4: Roxoperone [INN], 8-(3-(p-Fluorobenzoyl)propyl)-2-methyl-2,8-diazaspiro(4.5)decane-1,3-dione, 8-(4-p-Fluorophenyl-4-oxobutyl)-2-methyl-2,8-diazaspiro(4.5)decane-1,3-dione, Brn 0763388, F-33, Fr-33, Nsc 186062, R 7158, Roxoperon, Roxoperon [INN-Spanish], Roxoperonum, Roxoperonum [INN-Latin], Unii-5Rs1Cy853F, 2,8-Diazaspiro(4,5)decane-1,3-dione, 8-(3-(p-fluorobenzoyl)propyl)-2-methyl-, 2,8-Diazaspiro(4.5)decane-1,3-dione, 8-(4-(4-fluorophenyl)-4-oxobutyl)-2-methyl- (9CI), 8-[4-(4-Fluorophenyl)-4-Oxobutyl]-2-Methyl-2,8-Diazaspiro[4.5]Decane-1,3-Dione

Roxoperone

8-[4-(4-Fluorophenyl)-4-Oxobutyl]-3-Methyl-3,8-Diazaspiro[4.5]Decane-2,4-Dione is a chemical substance that has been shown to have an effect on lung function in mice. It was tested on CD-1 mice and found to increase the pulmonary resistance (R) of the lungs in response to methacholine challenge. 8-[4-(4-Fluorophenyl)-4-Oxobutyl]-3-Methyl-3,8-Diazaspiro[4.5]Decane-2,4-Dione also reduces the degree of lung inflammation and improves the respiratory function in mice with inflammatory airway disease. This compound has been shown to inhibit bacterial growth in vitro by inhibiting protein synthesis through inhibition of ribosomal activity.

CAS 2804-00-4: roxoperone

Roxoperone

Ref: TM-T34401

8-[4-(4-Fluorophenyl)-4-Oxobutyl]-3-Methyl-3,8-Diazaspiro[4.5]Decane-2,4-Dione

Ref: 3D-FF100261